Publications by authors named "Patrick Tilleul"

Claim this Profile
R
Randomised controlled trial to assess the impact of hospital-community pharmaceutical care on drug-related problems in oncology practice for at-risk outpatients treated with oral anticancer drugs-a French Society for Oncology Pharmacy (SFPO) study: DROP-SFPO study protocol.
Florence Ranchon, Laure Huot, Christophe Bardin, Isabelle Madelaine, Jean Louis Cazin, Patrick Tilleul

BMJ Open· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access Academy.
Elaine Julian, Tom Belleman, Maria João Garcia, Maureen Rutten-van Mölken, Robin Doeswijk, Patrick Tilleul

J Mark Access Health Policy· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of using trastuzumab biosimilars compared to trastuzumab original drugs to treat breast cancer in a hospital setting.
Eric C Barat, Marianne L E Arrii, Annaelle Soubieux-Bourbon, Mikaël Daouphars, Rémi Varin, Patrick R Tilleul

Breast· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Treatment Plan Optimization during the COVID-19 Pandemic: A Comprehensive Physicochemical Compatibility Study of Intensive Care Units Selected Drugs.
Maria Gloria Tarantini, Stéphanie Ramos, Philippe-Henri Secrétan, Laura Guichard, Lamia Hassani, Patrick Tilleul

Pharmaceutics· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction of biosimilar pegfilgrastim in France: Economic analysis of switching from originator.
Patrick R Tilleul, Barry S Rodgers-Gray, James O Edwards

J Oncol Pharm Pract· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shortage of sedatives and neuromuscular blockers during COVID-19 pandemic: The result of an overstocking procedure in French hospitals?
Déborah Montmeat, Claudine Gard, Mathieu Raux, Jean-Michel Constantin, Patrick Tilleul

Anaesth Crit Care Pain Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of diabetic foot ulcers: a 25% lidocaine topical cream formulation design, physicochemical and microbiological assessments.
Hassane Sadou Yayé, Antoine Faucheron, Léa Dupont, Fadwa El Kouari, Arnaud Fekkar, Patrick Tilleul

Eur J Hosp Pharm· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unmet needs in clinical nutrition in oncology: a multinational analysis of real-world evidence.
Riccardo Caccialanza, Francois Goldwasser, Oliver Marschal, Faith Ottery, Ingolf Schiefke, Patrick Tilleul

Ther Adv Med Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical and chemical stability of a generic etoposide formulation as an alternative to etoposide phosphate.
Hassane Sadou Yayé, Lamia Hassani, Philippe-Henri Secrétan, Martine Babiard, Haroun Aouati, Patrick Tilleul

J Pharm Biomed Anal· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Targeting of an ATG7-RAF1 Gene Fusion in Anaplastic Pleomorphic Xanthoastrocytoma With Leptomeningeal Dissemination.
Mehdi Touat, Nadia Younan, Philipp Euskirchen, Maxime Fontanilles, Karima Mokhtari, Patrick Tilleul

JCO Precis Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral drug reduction in highly experienced HIV-infected patients receiving a multidrug regimen: the ECOVIR study.
Marc-Antoine Valantin, Lise Durand, Marc Wirden, Lambert Assoumou, Fabienne Caby, Patrick Tilleul

J Antimicrob Chemother· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment.
Quentin Riller, Camille Cotteret, Helga Junot, Neila Benameur, Julien Haroche, Patrick Tilleul

J Neurol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management and cost analysis of cancer patients treated with G-CSF: a cohort study based on the French national healthcare insurance database.
Patrick Tilleul, William Jacot, Corinne Emery, Antoine Lafuma, Julie Gourmelen

J Med Econ· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating therapeutic usage of combined Ticagrelor and Aspirin through solid-state and analytical studies.
Hassane Sadou Yayé, Ivo B Rietveld, Maria Barrio, Philippe-Henri Secrétan, Antoine Faucheron, Patrick Tilleul

Eur J Pharm Sci· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France.
Maureen Watt, Aurélien Dinh, Alban Le Monnier, Patrick Tilleul

J Med Econ· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of managing anemia in end-stage renal disease: the experience of five French dialysis centers.
Jacques Rottembourg, Patrick Tilleul, Gilbert Deray, Antoine Lafuma, Lorraine Zakin

Eur J Health Econ· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the major degradation pathways of ticagrelor.
Hassane Sadou Yayé, Philippe-Henri Secrétan, Théo Henriet, Mélisande Bernard, Fatma Amrani, Patrick Tilleul

J Pharm Biomed Anal· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort study.
Helmi M'Kada, Hugo Perazzo, Mona Munteanu, Yen Ngo, Nittia Ramanujam, Patrick Tilleul

PLoS One· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter prospective observational study of the conformity of temozolomide prescriptions in France.
Patrick Tilleul, Melanie Brignone, Yasmine Hassani, Christelle Labrande, Stéphane Pedeboscq

Pharmacoepidemiol Drug Saf· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perception of alopecia by patients requiring chemotherapy for non-small-cell lung cancer: a willingness to pay study.
Mélisande Bernard, Mélanie Brignone, Alain Adehossi, Samuel Pefoura, Caroline Briquet, Patrick Tilleul

Lung Cancer· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A benefit for renal function after early switch to liposomal amphotericin B from conventional formulation in empirical antifungal treatment.
Françoise Isnard, Patrick Tilleul, Jean-Philippe Laporte, Patrice Chevallier, Arnaud Pigneux

Nephrol Dial Transplant· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated annual costs of prophylaxis and treatment of venous thromboembolic events associated with major orthopedic surgery in France.
Patrick Tilleul, Antoine LaFuma, Xavier Colin, Yves Ozier

Clin Appl Thromb Hemost· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Medico economic analysis in first line chemotherapy in advanced lung cancer].
Anne-Christine Joly, Géraldine Austruy-Chalendard, Sandra Camps, Mariette Baud, Alban Nérot, Patrick Tilleul

Therapie· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic low-molecular-weight heparin: prescription practice in an intensive care unit.
Patrick Tilleul, Gaëlle Tredan, Géraldine Austruy, Eric Maury, Georges Offenstadt

J Crit Care· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine once-weekly darbepoetin alfa administration is cost-effective in lung cancer patients with chemotherapy-induced anemia: a Markov analysis.
Isabelle Borget, Patrick Tilleul, Mariette Baud, Anne Christine Joly, Anne Daguenel

Lung Cancer· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis